News

Inspirational Research Grants Now Open

The Inspirational Research Grant is now open for applications for 2025 grants.

Following the recent announcement at the TOGA ASM 2024, we are thrilled to open the 2025 TOGA Inspirational Research Grants. These grants are designed to fuel innovative research and improve the lives of those affected by thoracic cancers.

Established through generous philanthropic donations, TOGA’s Inspirational Research Grants aim to bridge the funding gap for thoracic cancer research. With less than 6% of research funding allocated towards thoracic cancers, these grants offer a unique opportunity to drive advancements in prevention, treatment, and patient care.

Partnership with ALK Positive Australia Inc

TOGA is proud to partner with ALK Positive Australia Inc. to offer a dedicated grant for ALK+ NSCLC research. This collaboration aims to empower researchers and provide them with the necessary resources to make a significant impact on the lives of Australians battling this challenging disease.

The recipient of the ALK Positive Australia and TOGA Inspirational Research Grant for ALK+ NSCLC will receive a $50,000 grant.

Grant Details

  • Amount: $50,000
  • Duration: Two years
  • Eligibility: Projects must involve consumer representatives.

 

The 2024 recipients have stated that grants such as the Inspirational Research Grant have provided a great opportunity for research projects, “TOGA continues to be a vital platform for collaboration among thoracic cancer clinicians and researchers. Their advocacy for lung cancer resources is essential for driving cutting-edge research”, says Dr Wasek Faisel from Grampians Health. 

 

Additionally, at TOGA we strive to push research efforts further than we currently have. This is echoed by Dr Tracy Leong whose project is looking at defining epigenetic causes of immunotherapy resistance through liquid biopsies in lung cancer. “Immunotherapy is becoming increasingly important in lung cancer treatment. Our research focuses on identifying biomarkers of drug resistance and developing strategies to overcome it. The TRACKER project will be instrumental in supporting translational research efforts”, says Leong. 

Are you ready to make a difference?

Apply for a TOGA Inspirational Research Grant today! Your research could lead to groundbreaking discoveries and improve the lives of countless individuals affected by thoracic cancers.

Let’s work together to shape the future of thoracic oncology research.

 

Applications for the 2025 Inspirational Research Grant are now closed.

 

Share this

Facebook
Twitter
LinkedIn
The Thoracic Oncology Group of Australasia (TOGA) is thrilled to announce the recipients of the 2025 Inspirational Research Grants.
The Inspirational Research Grant has been created from philanthropic donations to increase research into prevention, treatment, or improved lives of those living with thoracic cancers.
Every year in November, we come together for Lung Cancer Awareness Month. It's a time to raise awareness about thoracic cancers, honour those affected, and
The Inspirational Research Grant has been created from philanthropic donations to increase research into prevention, treatment, or improved lives of those living with thoracic cancers.
ALK Positive Australia Inc. and the Thoracic Oncology Group of Australia (TOGA) are honoured to announce a new grant partnership dedicated to advancing ALK+ NSCLC
The Inspirational Research Grant has been created from philanthropic donations to increase research into prevention, treatment, or improved lives of those living with thoracic cancers.
Last week brought fantastic news for the fight against lung cancer. The Australian Government announced a record-breaking $1.89 billion investment in health and medical research,
Imagine a world where medical research doesn’t have to start from scratch. Imagine a treasure trove of valuable data readily available to answer new questions
On May 2, 2023, the Australian Government announced a significant investment of $263.8 million over four years to establish the national Lung Cancer Screening Program
Teletrials, also known as digi trials, are when a clinician at a primary site uses telehealth (videoconference or telephone calls) to enrol, consent, treat and/or